JScope
Start free trial
Home / Projects / Pharma & medical
Factory/PlantPharma & medical

Olympus completes new B Building at Nagano site for medical-device component production

Olympus CorporationTatsuno, NaganoPublished
Investment¥18B
PhaseCompleted
StartFeb 2025
CompletionJun 2026
Construction
Today
2026

Completed.

Olympus has completed the new B Building at its Nagano site in Tatsuno, Nagano, consolidating development and manufacturing functions and establishing a production base for key medical-device components. Construction began in February 2025, with full operation targeted for FY2026; the building has 17,665 sqm of total floor area and a total construction cost of approximately ¥18 billion.

Project facts

Owner
Olympus Corporation
Listing
7733 Tokyo
Facility
Factory/Plant
Sector
Pharma & medical
Location
Tatsuno, Nagano, Japan
Investment
¥18B — total construction cost
Scale / capacity
17,665 sqm total floor area
Contractor
Shimizu Corporation
Construction start
Feb 2025
Completion
Jun 2026
Announced
Jul 9, 2026

Figures and schedules are as announced by the company or the public body concerned; plans can change. Amounts that were not disclosed are recorded as not disclosed, never estimated.

Also in Nagano5 projects · ¥21.5B disclosedOn the map →

Tadano subsidiary starts operation of new aerial work platform plant in Nagano, boosting output 1.5xTadano Ltd.Completed¥3.5BNippon Shikizai opens Komoro cosmetics factoryNippon Shikizai, Inc.Completedn/dTadano Utility starts operations at new Yawata aerial work platform factoryTadano Ltd.Completedn/dPacific Consultants to launch floating solar demonstration using perovskite panels at Nagano dam reservoirPacific Consultants Co., Ltd.Plannedn/d

Latest in Pharma & medicalAll Pharma & medical →

Fujifilm to install ADC raw-material manufacturing equipment at Hirono plant

NewPharma & medicalFukushimaPlanned

Fujifilm will install payload and linker-payload manufacturing equipment, including reaction vessels, a filtration dryer and a preparative HPLC system, at the Hirono plant in Fukushima. The facility will also add a laboratory for process and analytical-method development, with operations scheduled to begin in 2028, enabling Fujifilm's one-stop domestic ADC CDMO service.

Shikoku Chuken to build new headquarters and research facility in Ayagawa

Pharma & medicalKagawaPlanned

Shikoku Chuken will build a new headquarters facility on land adjacent to its existing headquarters in Ayagawa, Kagawa. The facility will expand research and development using clinical specimens and testing data collected from across Shikoku, along with corporate planning, information processing and administrative functions; operations are scheduled to begin in January 2028.

JGC completes Chugai Pharma's UT3 biopharmaceutical API facility in Utsunomiya

Pharma & medicalTochigiCompleted

JGC Holdings completed the UT3 biopharmaceutical active pharmaceutical ingredient facility for Chugai Pharmaceutical Industry at its Utsunomiya plant in May 2026. The four-story facility supports clinical-trial manufacturing through initial commercial production and includes continuous-production capabilities, solar panels and other environmental features; it was handed over on May 14, 2026.

Lion to build new pharmaceutical plant in Hung Yen, Vietnam

Pharma & medicalHung YenPlanned¥1.5B

Lion has approved construction of a new pharmaceutical plant through its wholly owned Vietnamese subsidiary Merap Lion. The facility will produce prescription and over-the-counter solid-dose medicines, including tablets and granules, with operations planned to begin in the second half of 2030.